# Effects of Lactobacillus Delbruckii Lactis DN111244 Fermented Milk Consumption on Plasma Lipids Levels in Hypercholesterolaemic Adults

> **NCT01353820** · NA · COMPLETED · sponsor: **Danone Global Research & Innovation Center** · enrollment: 100 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DIETARY_SUPPLEMENT:** 1- Low fat drinkable fermented by Lactobacillus Delbruckii lactis (DN111244) - >10E8 <5.10E9 cfu/mL
- **DIETARY_SUPPLEMENT:** 2- Low fat drinkable fermented by S. thermophilus and L. bulgaricus

## Key facts

- **NCT ID:** NCT01353820
- **Lead sponsor:** Danone Global Research & Innovation Center
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2008-12
- **Final completion:** 2009-03
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2016-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01353820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01353820, "Effects of Lactobacillus Delbruckii Lactis DN111244 Fermented Milk Consumption on Plasma Lipids Levels in Hypercholesterolaemic Adults". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01353820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*